IT201700087359A1 - Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale - Google Patents

Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale

Info

Publication number
IT201700087359A1
IT201700087359A1 IT102017000087359A IT201700087359A IT201700087359A1 IT 201700087359 A1 IT201700087359 A1 IT 201700087359A1 IT 102017000087359 A IT102017000087359 A IT 102017000087359A IT 201700087359 A IT201700087359 A IT 201700087359A IT 201700087359 A1 IT201700087359 A1 IT 201700087359A1
Authority
IT
Italy
Prior art keywords
treatment
amino acids
diseases associated
compositions including
including amino
Prior art date
Application number
IT102017000087359A
Other languages
English (en)
Inventor
Paolo Luca Maria Giorgetti
Original Assignee
Professional Dietetics Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics Spa filed Critical Professional Dietetics Spa
Priority to IT102017000087359A priority Critical patent/IT201700087359A1/it
Priority to US16/634,330 priority patent/US11337946B2/en
Priority to EP18753465.6A priority patent/EP3658132B1/en
Priority to KR1020247014645A priority patent/KR20240063205A/ko
Priority to PT187534656T priority patent/PT3658132T/pt
Priority to SG11201912103TA priority patent/SG11201912103TA/en
Priority to MYPI2020000106A priority patent/MY200975A/en
Priority to KR1020207003492A priority patent/KR102566297B1/ko
Priority to CN201880047542.0A priority patent/CN110996935A/zh
Priority to JP2019566579A priority patent/JP7266767B2/ja
Priority to HUE18753465A priority patent/HUE059050T2/hu
Priority to EP21174744.9A priority patent/EP3915553A1/en
Priority to CA3070197A priority patent/CA3070197A1/en
Priority to KR1020237026054A priority patent/KR20230117642A/ko
Priority to ES18753465T priority patent/ES2923126T3/es
Priority to PL18753465.6T priority patent/PL3658132T3/pl
Priority to MX2020001083A priority patent/MX2020001083A/es
Priority to PCT/IB2018/055425 priority patent/WO2019021135A1/en
Priority to AU2018306540A priority patent/AU2018306540B2/en
Priority to RU2019141152A priority patent/RU2770660C9/ru
Priority to DK18753465.6T priority patent/DK3658132T3/da
Priority to RS20220627A priority patent/RS63422B1/sr
Priority to LTEPPCT/IB2018/055425T priority patent/LT3658132T/lt
Priority to BR112020001471-0A priority patent/BR112020001471A2/pt
Publication of IT201700087359A1 publication Critical patent/IT201700087359A1/it
Priority to CL2020000220A priority patent/CL2020000220A1/es
Priority to MX2022010774A priority patent/MX2022010774A/es
Priority to PH12020500190A priority patent/PH12020500190A1/en
Priority to US17/724,537 priority patent/US11957651B2/en
Priority to JP2023035509A priority patent/JP7513311B2/ja
Priority to AU2023266256A priority patent/AU2023266256A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
IT102017000087359A 2017-07-28 2017-07-28 Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale IT201700087359A1 (it)

Priority Applications (30)

Application Number Priority Date Filing Date Title
IT102017000087359A IT201700087359A1 (it) 2017-07-28 2017-07-28 Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
PL18753465.6T PL3658132T3 (pl) 2017-07-28 2018-07-20 Kompozycje zawierające aminokwasy do zastosowania w leczeniu chorób związanych z dysfunkcją mitochondrialną
MX2020001083A MX2020001083A (es) 2017-07-28 2018-07-20 Composiciones que comprenden aminoacidos para su uso en el tratamiento de enfermedades relacionadas con la disfuncion mitocondrial.
EP18753465.6A EP3658132B1 (en) 2017-07-28 2018-07-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
PT187534656T PT3658132T (pt) 2017-07-28 2018-07-20 Composições contendo aminoácidos para utilização no tratamento de doenças relacionadas com a disfunção mitocondrial
SG11201912103TA SG11201912103TA (en) 2017-07-28 2018-07-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
MYPI2020000106A MY200975A (en) 2017-07-28 2018-07-20 "Compositions Comprising Amino acids for use in the Treatment of Mitochondrial Dysfunction-Related Diseases"
KR1020207003492A KR102566297B1 (ko) 2017-07-28 2018-07-20 미토콘드리아 기능 이상-관련 질병의 치료에 사용하기 위한 아미노산을 포함하는 조성물(compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related disease)
CN201880047542.0A CN110996935A (zh) 2017-07-28 2018-07-20 用于治疗线粒体功能障碍相关疾病的包含氨基酸的组合物
JP2019566579A JP7266767B2 (ja) 2017-07-28 2018-07-20 ミトコンドリア機能障害関連疾患の治療に使用するための、アミノ酸を備える組成物
HUE18753465A HUE059050T2 (hu) 2017-07-28 2018-07-20 Aminosavakat tartalmazó készítmények mitokondriális rendellenességgel összefüggõ betegségek kezelésében történõ alkalmazásra
EP21174744.9A EP3915553A1 (en) 2017-07-28 2018-07-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related neurodegenerative diseases
CA3070197A CA3070197A1 (en) 2017-07-28 2018-07-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
KR1020237026054A KR20230117642A (ko) 2017-07-28 2018-07-20 미토콘드리아 기능 이상-관련 질병의 치료에 사용하기위한 아미노산을 포함하는 조성물
ES18753465T ES2923126T3 (es) 2017-07-28 2018-07-20 Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial
US16/634,330 US11337946B2 (en) 2017-07-28 2018-07-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
KR1020247014645A KR20240063205A (ko) 2017-07-28 2018-07-20 미토콘드리아 기능 이상-관련 질병의 치료에 사용하기 위한 아미노산을 포함하는 조성물
PCT/IB2018/055425 WO2019021135A1 (en) 2017-07-28 2018-07-20 COMPOSITIONS COMPRISING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES RELATED TO MITOCHONDRIAL DYSFUNCTION
AU2018306540A AU2018306540B2 (en) 2017-07-28 2018-07-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
RU2019141152A RU2770660C9 (ru) 2017-07-28 2018-07-20 Композиции, содержащие аминокислоты, для применения в лечении заболеваний, ассоциированных с митохондриальными дисфункциями
DK18753465.6T DK3658132T3 (da) 2017-07-28 2018-07-20 Sammensætninger omfattende aminosyrer til anvendelse ved behandling af mitokondrielle dysfunktion-relaterede sygdomme
RS20220627A RS63422B1 (sr) 2017-07-28 2018-07-20 Kompozicije koje sadrže aminokiseline za upotrebu u lečenju bolesti povezanih sa mitohondrijalnom disfunkcijom
LTEPPCT/IB2018/055425T LT3658132T (lt) 2017-07-28 2018-07-20 Kompozicijos, apimančios aminorūgštis, skirtos panaudoti gydant su mitochondrijų disfunkcija susijusias ligas
BR112020001471-0A BR112020001471A2 (pt) 2017-07-28 2018-07-20 Composição para promover a biogênese mitocondrial emelhorar a função mitocondrial, e, uso da composição
CL2020000220A CL2020000220A1 (es) 2017-07-28 2020-01-27 Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
MX2022010774A MX2022010774A (es) 2017-07-28 2020-01-27 Composiciones que comprenden aminoacidos para su uso en el tratamiento de enfermedades relacionadas con la disfuncion mitocondrial.
PH12020500190A PH12020500190A1 (en) 2017-07-28 2020-01-27 Compositions comprising amino acids for use in the treatment of mitochondrial dysfuntion-related diseases
US17/724,537 US11957651B2 (en) 2017-07-28 2022-04-20 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
JP2023035509A JP7513311B2 (ja) 2017-07-28 2023-03-08 ミトコンドリア機能障害関連疾患の治療に使用するための、アミノ酸を備える組成物
AU2023266256A AU2023266256A1 (en) 2017-07-28 2023-11-14 Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000087359A IT201700087359A1 (it) 2017-07-28 2017-07-28 Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale

Publications (1)

Publication Number Publication Date
IT201700087359A1 true IT201700087359A1 (it) 2019-01-28

Family

ID=60628070

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000087359A IT201700087359A1 (it) 2017-07-28 2017-07-28 Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale

Country Status (22)

Country Link
US (2) US11337946B2 (it)
EP (2) EP3915553A1 (it)
JP (1) JP7266767B2 (it)
KR (3) KR102566297B1 (it)
CN (1) CN110996935A (it)
AU (2) AU2018306540B2 (it)
BR (1) BR112020001471A2 (it)
CA (1) CA3070197A1 (it)
CL (1) CL2020000220A1 (it)
DK (1) DK3658132T3 (it)
ES (1) ES2923126T3 (it)
HU (1) HUE059050T2 (it)
IT (1) IT201700087359A1 (it)
LT (1) LT3658132T (it)
MX (2) MX2020001083A (it)
MY (1) MY200975A (it)
PH (1) PH12020500190A1 (it)
PL (1) PL3658132T3 (it)
PT (1) PT3658132T (it)
RS (1) RS63422B1 (it)
SG (1) SG11201912103TA (it)
WO (1) WO2019021135A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700087376A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201700087359A1 (it) * 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201900002109A1 (it) * 2019-02-13 2020-08-13 Professional Dietetics Spa Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale
JP2021038147A (ja) * 2019-08-30 2021-03-11 国立大学法人 鹿児島大学 ミトコンドリア生合成促進剤
IT202000000442A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
IT202000021664A1 (it) * 2020-09-14 2022-03-14 Iaf Network S P A Formulazione amminoacidica bilanciata
TW202308604A (zh) * 2021-05-10 2023-03-01 國立大學法人東北大學 肌肉量增加用組成物
IT202100029726A1 (it) * 2021-11-24 2023-05-24 Professional Dietetics Spa Composizioni oftalmiche per il trattamento di lesioni corneali

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140315788A1 (en) * 2013-04-19 2014-10-23 Board Of Trustees Of The University Of Arkansas Methods for improving heart function
CA2972889A1 (en) * 2015-03-20 2016-09-29 Jorge Antonio Hernandez Miramontes Mixture of carboxylic acids for treating patients with kidney failure
WO2016179657A1 (en) * 2015-05-11 2016-11-17 Newcastle Innovation Limited Amino acid supplementation
WO2016181335A1 (en) * 2015-05-14 2016-11-17 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001521002A (ja) 1997-10-24 2001-11-06 コーネル リサーチ ファンデーション インク． 脳の代謝機能不全のための栄養補充剤
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
ITTO20010580A1 (it) 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
ITTO20010804A1 (it) 2001-08-08 2003-02-08 Professional Dietetics Srl Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
US6620850B2 (en) 2001-09-19 2003-09-16 University Of Florida Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
ITTO20030789A1 (it) 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento
WO2007049818A1 (ja) 2005-10-27 2007-05-03 Ajinomoto Co., Inc. 抗脂肪肝、抗肥満及び抗高脂血症用組成物
US7982066B2 (en) * 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
JP2007161642A (ja) 2005-12-14 2007-06-28 Kyowa Hakko Kogyo Co Ltd アルコール性肝障害抑制剤
JP6090836B2 (ja) 2011-02-17 2017-03-08 Ｅａファーマ株式会社 化学療法剤の抗腫瘍活性増強剤
WO2012147901A1 (ja) 2011-04-28 2012-11-01 味の素株式会社 抗癌剤副作用改善用組成物
US20130084378A1 (en) 2011-09-30 2013-04-04 Daesang Corporation Amino acid seasoning compositions comprising l-glutamic acid and l-lysine
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
WO2013188874A1 (en) 2012-06-15 2013-12-19 Gencia Corporation Methods of mitigating side effects of radiation exposure and chemotherapy
CN102772407B (zh) 2012-08-01 2014-09-17 岳茂兴 一种促进神经损伤修复的药物组合物及其应用
JP6013670B1 (ja) 2014-12-09 2016-10-25 株式会社日本自然発酵 老化抑制剤
US20180221457A1 (en) 2015-07-31 2018-08-09 Val-Chum, Limited Partnership Glycerol-3-phosphate phosphatase activators
US20180344677A1 (en) 2015-11-27 2018-12-06 Doublegood Ab Food supplement and composition for treating the metabolic syndrome
CN110678172A (zh) 2017-04-28 2020-01-10 胺细拉健康公司 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法
IT201700087376A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201700087359A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
CN111417391B (zh) 2017-10-02 2024-06-18 佛罗里达大学研究基金会公司 用于抑制肿瘤生长的材料和方法
KR20200129120A (ko) * 2018-03-05 2020-11-17 아지노모토 가부시키가이샤 인지 기능 개선용 조성물 및 불안양 증상 개선용 조성물, 및 뇌 위축 억제용 조성물
IT201800006725A1 (it) 2018-06-27 2019-12-27 Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche
IT201900002109A1 (it) 2019-02-13 2020-08-13 Professional Dietetics Spa Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale
KR20220104188A (ko) 2019-11-11 2022-07-26 엘지전자 주식회사 무선통신시스템에서 동작하는 차량용 분산 안테나 시스템 및 그 동작 방법
IT202000000454A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
IT202000000442A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia
WO2022266480A1 (en) 2021-06-17 2022-12-22 Axcella Health Inc. Methods of predicting liver fat content and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140315788A1 (en) * 2013-04-19 2014-10-23 Board Of Trustees Of The University Of Arkansas Methods for improving heart function
CA2972889A1 (en) * 2015-03-20 2016-09-29 Jorge Antonio Hernandez Miramontes Mixture of carboxylic acids for treating patients with kidney failure
WO2016179657A1 (en) * 2015-05-11 2016-11-17 Newcastle Innovation Limited Amino acid supplementation
WO2016181335A1 (en) * 2015-05-14 2016-11-17 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LORENZA BROCCA ET AL: "Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice", JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, BIOMED CENTRAL LTD, LO, vol. 10, no. 1, 3 April 2013 (2013-04-03), pages 19, XP021147020, ISSN: 1550-2783, DOI: 10.1186/1550-2783-10-19 *

Also Published As

Publication number Publication date
MX2022010774A (es) 2023-02-23
US20200230093A1 (en) 2020-07-23
EP3658132B1 (en) 2022-04-13
MX2020001083A (es) 2022-08-31
KR102566297B1 (ko) 2023-08-10
KR20230117642A (ko) 2023-08-08
RU2019141152A (ru) 2021-08-30
MY200975A (en) 2024-01-27
LT3658132T (lt) 2022-07-25
CN110996935A (zh) 2020-04-10
PH12020500190A1 (en) 2020-09-28
KR20200033872A (ko) 2020-03-30
AU2018306540B2 (en) 2023-11-30
RS63422B1 (sr) 2022-08-31
HUE059050T2 (hu) 2022-10-28
CL2020000220A1 (es) 2020-07-31
BR112020001471A2 (pt) 2020-09-15
US11957651B2 (en) 2024-04-16
RU2770660C2 (ru) 2022-04-20
KR20240063205A (ko) 2024-05-09
RU2019141152A3 (it) 2021-09-10
JP2023071939A (ja) 2023-05-23
PT3658132T (pt) 2022-07-08
US20220249418A1 (en) 2022-08-11
US11337946B2 (en) 2022-05-24
WO2019021135A1 (en) 2019-01-31
AU2023266256A1 (en) 2023-12-07
EP3658132A1 (en) 2020-06-03
CA3070197A1 (en) 2019-01-31
SG11201912103TA (en) 2020-01-30
PL3658132T3 (pl) 2022-08-01
EP3915553A1 (en) 2021-12-01
JP2020528400A (ja) 2020-09-24
DK3658132T3 (da) 2022-07-04
AU2018306540A1 (en) 2020-02-20
JP7266767B2 (ja) 2023-05-01
ES2923126T3 (es) 2022-09-23

Similar Documents

Publication Publication Date Title
IT201700087359A1 (it) Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
CL2020002043A1 (es) Métodos y composiciones para la entrega de proteínas terapeuticas.
MA46743A (fr) Acides propioniques à substitution en position 3 en tant qu'inhibiteurs d'intégrine alpha v
AR103680A1 (es) Inhibidores selectivos de bace1
MA46746A (fr) Amides d'azole et amines en tant qu'inhibiteurs d'intégrine alpha v
MA53275A (fr) Carboxamides en tant qu'inhibiteurs de protéase spécifiques de l'ubiquitine
MA49841A (fr) Carboxamides utilisées en tant qu'inhibiteurs de protéase spécifique de l'ubiquitine
MA45684A (fr) Protéine d'apport du cerveau
MA53643A (fr) Dioxocyclobuténylamino-3-hydroxy-picolinamides n-substitués utiles en tant qu'inhibiteurs de ccr6
MA43685A (fr) Solutions aqueuses d'acides aminés n-acylés
MA43825A (fr) Schémas posologiques pour le traitement d'infections fongiques
BR112017021583A2 (pt) métodos para o tratamento de transtornos inflamatórios
DK3476395T3 (da) Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme
IT201700087376A1 (it) Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
MA54043A (fr) Cercueil notamment pour l'inhumation en pleine terre
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
GT201700227A (es) Derivados de aminohidrotiazina fusionados con tetrahidrofurano los cuales son utiles en el tratamiento de la enfermedad de alzheimer
DK3542906T3 (da) Marksprøjte med dysesamlinger
CO2017000211A2 (es) Compuestos, composición farmacéutica y su uso en el tratamiento de enfermedades neurodegenerativas
IT201600122310A1 (it) Composizione per uso nella terapia di alterazioni dell'intestino
IT201700111939A1 (it) Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
ITUB20153759A1 (it) Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo
IT201700066486A1 (it) Siero sanguigno per uso nel trattamento di patologie neurodegenerative oftalmologiche